Locations
San Francisco, CA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
51-200 employees
Stage
Series C+
founded in
2017
Unlearn.AI is a biotech AI company that develops a digital twin service for clinical trials, enhancing healthcare by predicting health outcomes before symptoms appear. Their innovative TwinRCT solution allows biopharma partners to conduct faster and more successful clinical trials by utilizing machine learning to create prognostic digital twins for each patient. This approach improves the precision of treatment effect estimations and optimizes clinical trial design, positioning Unlearn.AI as a leader in the intersection of AI and clinical research, with a focus on neuroscience, immunology, and metabolic diseases.
Is this your company?
Something looks off?
On-site & Remote